dELiAs, Inc.

CIK:0001337885|SEC Filings

Note 1 - Business and Basis of Presentation (Details) - Discontinued Operations (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
	Aug. 03, 2013	Aug. 03, 2013
Discontinued Operations [Abstract]
Net revenues	$ 2,813	$ 12,586
Cost of goods sold	2,021	8,445
Gross profit	792	4,141
Selling, general and administrative expenses	1,803	5,239
Other operating income	(17)	(82)
Total expenses	1,786	5,157
Operating loss	(994)	(1,016)
Loss from discontinued operations, net of income taxes	$ (994)	$ (1,016)

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Aug. 02, 2014	Aug. 03, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (25,202)	$ (21,319)
Loss from discontinued operations		(1,016)
Loss from continuing operations	(25,202)	(20,303)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,638	4,609
Amortization of deferred financing fees	143	674
Interest related to converted notes	570
Stock-based compensation	1,212	588
Changes in operating assets and liabilities:
Inventories	(9,689)	(1,936)
Prepaid catalog costs and other assets	903	(1,797)
Restricted cash	1,048	(11,266)
Income taxes payable	61	43
Accounts payable, accrued expenses and other liabilities	(3,152)	(5,568)
Total adjustments	(5,266)	(14,653)
Net cash used in operating activities of continuing operations	(30,468)	(34,956)
Net cash used in operating activities of discontinued operations		(1,266)
NET CASH USED IN OPERATING ACTIVITIES	(30,468)	(36,222)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(2,206)	(1,658)
Net cash used in investing activities of continuing operations	(2,206)	(1,658)
Net cash provided by investing activities of discontinued operations		2,591
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES	(2,206)	933
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of issuance costs		13,926
Proceeds from issuance of Series B preferred stock, net of issuance costs	18,515
Purchase of treasury stock	(4)	(37)
Payment of deferred financing fees		(1,007)
Net (repayments) borrowings on bank loan payable	(9,130)	9,799
Sale of notes payable, net of issuance costs	23,084
Proceeds from sale of convertible notes		21,775
Restricted cash		(21,775)
NET CASH PROVIDED BY FINANCING ACTIVITIES	32,465	22,681
NET DECREASE IN CASH AND CASH EQUIVALENTS	(209)	(12,608)
CASH AND CASH EQUIVALENTS, beginning of period	3,280	16,812
CASH AND CASH EQUIVALENTS, end of period	3,071	4,204
SUPPLEMETAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	772	1,487
Cash paid during the period for taxes	70	61
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Capital expenditures incurred not yet paid	212	829
Accrual of dividends payable	1,195
Conversion of notes payable to preferred stock	23,084
Conversion of preferred stock to common stock	1,940
Retirement of treasury stock	$ 68

Condensed Consolidated Balance Sheets (August 2, 2014 and August 3, 2013 Unaudited) (USD $) In Thousands, unless otherwise specified	Aug. 02, 2014	Feb. 01, 2014	Aug. 03, 2013
CURRENT ASSETS:
Cash and cash equivalents	$ 3,071	$ 3,280	$ 4,204
Inventories, net	29,210	19,521	26,776
Prepaid catalog costs	1,225	1,406	1,553
Restricted cash	7,245	8,190	31,838
Other current assets	5,030	5,752	6,385
TOTAL CURRENT ASSETS	45,781	38,149	70,756
PROPERTY AND EQUIPMENT, NET	25,570	27,745	33,606
INTANGIBLE ASSETS, NET	2,419	2,419	2,419
RESTRICTED CASH	1,100	1,203	1,203
OTHER ASSETS	720	863	1,006
TOTAL ASSETS	75,590	70,379	108,990
CURRENT LIABILITIES:
Accounts payable	15,221	15,550	21,483
Bank loan payable	5,408	14,538	9,799
Accrued expenses and other current liabilities	8,261	10,406	11,618
Convertible notes payable			21,775
Accrued dividend payable	1,195
Income taxes payable	661	600	666
TOTAL CURRENT LIABILITIES	30,746	41,094	65,341
DEFERRED CREDITS AND OTHER LONG-TERM LIABILITIES	6,804	8,224	9,229
TOTAL LIABILITIES	37,550	49,318	74,570
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred Stock; $.001 par value, 25,000,000 shares authorized: Series B Convertible Preferred stock, (liquidation preference of $43,355) stated value $100 per share, 441,000 shares designated and 421,600, -0- and -0- shares issued and outstanding, respectively	0
Common Stock; $.001 par value, 200,000,000 shares authorized: 73,243,560; 69,415,451 and 47,822,776 shares outstanding, respectively	73	69	48
Additional paid-in capital	181,128	138,296	114,449
Accumulated deficit	(143,157)	(117,232)	(80,040)
Treasury stock at cost; 6,012; 49,807 and 24,878 shares, respectively	(4)	(72)	(37)
TOTAL STOCKHOLDERS' EQUITY	38,040	21,061	34,420
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 75,590	$ 70,379	$ 108,990